Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$30.49 - $48.49 $3.09 Million - $4.91 Million
-101,272 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$41.66 - $52.52 $158,266 - $199,523
3,799 Added 3.9%
101,272 $4.89 Million
Q2 2021

Aug 16, 2021

BUY
$36.62 - $51.69 $65,439 - $92,370
1,787 Added 1.87%
97,473 $4.4 Million
Q1 2021

May 17, 2021

BUY
$41.56 - $59.88 $236,143 - $340,238
5,682 Added 6.31%
95,686 $4.62 Million
Q4 2020

Feb 16, 2021

SELL
$36.08 - $56.47 $2.08 Million - $3.25 Million
-57,563 Reduced 39.01%
90,004 $4.85 Million
Q3 2020

Nov 16, 2020

BUY
$33.26 - $40.48 $1.87 Million - $2.28 Million
56,258 Added 61.61%
147,567 $5.44 Million
Q2 2020

Aug 14, 2020

BUY
$24.21 - $31.02 $1.2 Million - $1.54 Million
49,541 Added 118.61%
91,309 $2.83 Million
Q1 2020

May 15, 2020

SELL
$20.5 - $34.53 $198,501 - $334,353
-9,683 Reduced 18.82%
41,768 $1.15 Million
Q4 2019

Feb 18, 2020

BUY
$18.96 - $29.84 $975,510 - $1.54 Million
51,451 New
51,451 $1.51 Million
Q3 2019

Nov 14, 2019

SELL
$19.12 - $26.24 $2.52 Million - $3.46 Million
-131,797 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$19.57 - $24.1 $2.39 Million - $2.94 Million
121,900 Added 1231.69%
131,797 $2.89 Million
Q1 2019

May 15, 2019

BUY
$12.14 - $20.46 $120,149 - $202,492
9,897 New
9,897 $203,000
Q4 2018

Feb 14, 2019

SELL
$11.24 - $18.5 $236,871 - $389,869
-21,074 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$12.5 - $15.38 $123,412 - $151,846
9,873 Added 88.14%
21,074 $323,000
Q2 2018

Aug 14, 2018

BUY
$7.99 - $14.05 $89,495 - $157,374
11,201 New
11,201 $147,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $1.81B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.